Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2023-01-31 Report Publication Anno…
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
Kolinpharma, calendario eventi societari 2023
Report Publication Announcement Classification · 1% confidence The document is an official announcement from KOLINPHARMA S.p.A. published on January 31, 2023, titled 'Kolinpharma, calendario eventi societari 2023' (Kolinpharma, corporate events calendar 2023). It explicitly lists future dates for Board Meetings (Consiglio di Amministrazione) concerning financial results (KPIs, draft annual report, half-year report) and the Shareholders' Meeting (Assemblea degli Azionisti). This document is not the financial report itself (like 10-K or IR), nor is it a transcript (CT) or a management discussion (MDA). It is an announcement detailing the schedule of future corporate events, which aligns best with a general regulatory announcement or a specific announcement about future reporting schedules. Given the options, since it announces the schedule for key corporate events including financial reporting dates and shareholder meetings, it functions as a regulatory disclosure about future corporate actions and reporting timelines. It is too specific for the general 'RNS' fallback, but it is not a specific report type. However, since it is a formal announcement published via regulatory channels (Euronext Growth Milan) detailing the schedule of future mandatory corporate events (like AGM/financial report releases), it is best classified as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a report, but here it announces the *schedule* of reports. Given the content is purely a schedule of future corporate events, RNS (Regulatory Filings - general fallback) is the most appropriate category for this type of forward-looking schedule announcement that doesn't fit the other specific categories.
2023-01-31 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and its subject is "Kolinpharma, aggiornamento buy-back" (Kolinpharma, buy-back update). The content details the execution of a share buy-back program for the period January 23, 2023 – January 27, 2023, including the number of shares purchased and the total consideration. This is a specific announcement regarding the company's own shares being transacted. This directly matches the definition for 'Transaction in Own Shares' (Code: POS). Although it involves capital management, the specific focus on repurchases makes POS more accurate than CAP.
2023-01-30 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and its subject is 'Kolinpharma, aggiornamento buy-back' (Kolinpharma, buy-back update). The content details the purchase of 1,000 own shares by the company during a specific period (January 16, 2023 – January 20, 2023). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing type code is POS.
2023-01-25 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled 'COMUNICATO STAMPA PRICE SENSITIVE' (Price Sensitive Press Release) and its subject is 'Kolinpharma, aggiornamento buy-back' (Kolinpharma, buy-back update). The content details the transactions made under the company's share repurchase program for the period January 9, 2023, to January 13, 2023, including the number of shares bought, weighted average price, and total consideration. This explicitly reports on the company's activity regarding buying back its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). Although it is a press release, the core subject matter is the transaction itself, making POS more specific than RPA or RNS.
2023-01-16 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and its subject is "Kolinpharma, aggiornamento buy-back" (Kolinpharma, buy-back update). The content details the purchase of the company's own shares during a specific period (January 2 to January 6, 2023), including the number of shares bought, the average price, and the total consideration. This activity—a company repurchasing its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing type code is POS.
2023-01-11 Italian
Kolinpharma, aggiornamento buy-back
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" (Price Sensitive Press Release) and its subject is "Kolinpharma, aggiornamento buy-back" (Kolinpharma, buy-back update). The content details the purchase of 'azioni proprie' (own shares) by the company during the period December 27-30, 2022, including the number of shares bought, the average price, and the total consideration. This activity—a company repurchasing its own stock—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is a press release, the core subject matter is the transaction itself, making POS more specific than RPA or RNS.
2023-01-09 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.